Xu et al. reported that stromal AREG induced programmed cell death 1 ligand (PD-L1) expression in prostate cancer cells and created an immunosuppressive tumor microenvironment (TME) against cytotoxic lymphocytes via immune checkpoint activation [16]. Here, CD274 is linked to prostate carcinoma.